4.6 Article

Determination of Methyl Methanesulfonate and Ethyl Methylsulfonate in New Drug for the Treatment of Fatty Liver Using Derivatization Followed by High-Performance Liquid Chromatography with Ultraviolet Detection

Related references

Note: Only part of the references are listed.
Review Chemistry, Analytical

Analytical control strategies for mutagenic impurities: Current challenges and future opportunities?

Andrew Teasdale et al.

TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2018)

Article Biochemical Research Methods

Matrix precipitation: A general strategy to eliminate matrix interference for pharmaceutical toxic impurities analysis

Xiaojing Yang et al.

JOURNAL OF CHROMATOGRAPHY A (2015)

Article Chemistry, Applied

Do Carboxylic/Sulfonic Acid Halides Really Present a Mutagenic and Carcinogenic Risk as Impurities in Final Drug Products?

Alexander Amberg et al.

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2015)

Article Pharmacology & Pharmacy

Simultaneous determination of alkyl mesilates and alkyl besilates in finished drug products by direct injection GC/MS

Uwe Wollein et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)

Article Chemistry, Analytical

Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate

Antonia Garcia et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2012)

Article Pharmacology & Pharmacy

Drug substances presented as sulfonic acid salts: overview of utility, safety and regulation

David P. Elder et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)

Article Chemistry, Analytical

Development and validation of GC-MS method for the determination of methyl methane sulfonate and ethyl methanesulfonate in imatinib mesylate

K. Ramakrishna et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)